Patents by Inventor Weiling Liang

Weiling Liang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230146395
    Abstract: The present disclosure provides compounds that are inhibitors of PIKfyve and/or PI3 kinases, and are therefore useful for the treatment of neurological diseases treatable by inhibition of PIKfyve and/or PI3 kinases. Also provided are pharmaceutical compositions containing such compounds, and methods of treatment of neurological diseases using such compounds.
    Type: Application
    Filed: March 8, 2021
    Publication date: May 11, 2023
    Applicant: Verge Analytics, Inc.
    Inventors: Mark D. Rosen, Robert A. Galemmo, Jr., Weiling Liang, Irene Y. Choi, Brian Kopec, Jane Rhodes
  • Publication number: 20230133203
    Abstract: The present disclosure provides compounds that are inhibitors of PIKfyve kinases useful for the treatment of neurological diseases treatable by inhibition of PIKfyve. Also provided are pharmaceutical compositions containing such compounds, and methods of treatment using such compounds.
    Type: Application
    Filed: January 12, 2021
    Publication date: May 4, 2023
    Applicant: Verge Analytics, Inc.
    Inventors: Mark D. Rosen, Robert A. Galemmo, JR., Weiling Liang, Brian Kopec, Irene Y. Choi, Jane Rhodes
  • Publication number: 20230038929
    Abstract: The present disclosure provides compounds that are inhibitors of PIKfyve and/or PI3 kinases, and are therefore useful for the treatment of neurological diseases that are treatable by inhibition of PIKfyve. Also provided are pharmaceutical compositions containing such compounds, and methods of treatment using such compounds.
    Type: Application
    Filed: December 4, 2020
    Publication date: February 9, 2023
    Applicant: Verge Analytics, Inc.
    Inventors: Mark D. Rosen, Robert A. Galemmo, JR., William J. Guilford, Weiling Liang, Irene Y. Choi, Bryan Kopek, Jane Rhodes
  • Patent number: 9309248
    Abstract: Disclosed are compounds of Formula (I), or pharmaceutically acceptable salts thereof, wherein W, Y, Z, R1, R2, R3 and R4 are as described in this application, and methods of using the compounds in the treatment of cancer.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: April 12, 2016
    Assignee: HOFFMANN-LA ROCHE INC.
    Inventors: Joan Heather Hogg, Robert Francis Kester, Weiling Liang, Weiya Yun
  • Publication number: 20150266879
    Abstract: Disclosed are compounds of Formula (I), or pharmaceutically acceptable salts thereof, wherein W, Y, Z, R1, R2, R3 and R4 are as described in this application, and methods of using the compounds in the treatment of cancer.
    Type: Application
    Filed: October 8, 2013
    Publication date: September 24, 2015
    Inventors: Joan Heather Hogg, Robert Francis Kester, Weiling Liang, Weiya Yun
  • Publication number: 20100056535
    Abstract: The present invention provides compounds for treating or preventing an HIV infection, or treating AIDS or ARC comprising administering a compound according to Formulae I and II wherein Q, R1, R2, and R3 are defined as described herein.
    Type: Application
    Filed: September 4, 2009
    Publication date: March 4, 2010
    Inventors: Nidhi Arora, Roland Joseph Billedeau, Joshua Kennedy-Smith, Weiling Liang, Ralf Roetz, Zachary Kevin Sweeney
  • Publication number: 20060199821
    Abstract: The invention is directed to compounds and methods to inhibit p38 kinase wherein the compounds are a pyrimidine or pyridine coupled to two mandatory substituents.
    Type: Application
    Filed: August 3, 2005
    Publication date: September 7, 2006
    Applicant: Scios, Inc.
    Inventors: Richard Tester, Xuefei Tan, Kurt Schinzel, Imad Nashashibi, Gregory Luedtke, Weiling Liang, Joon Jung, R. Goehring, Sundeep Dugar, Steven Do